• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

224.66 -2.27 (-1.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,906,922
Open 227.47
Bid (Size) 199.99 (100)
Ask (Size) 226.60 (100)
Prev. Close 226.93
Today's Range 220.74 - 228.00
52wk Range 105.00 - 243.32
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Stocks Split into Two Camps: Profitable Operators vs. High-Growth Speculation ↗
June 18, 2026
Via Chartmill
Topics Cannabis
News headline image
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026
From AbCellera Biologics Inc.
Via Business Wire

Performance

YTD
+29.7%
+29.7%
1 Month
-6.0%
-6.0%
3 Month
+24.4%
+24.4%
6 Month
+34.5%
+34.5%
1 Year
+109.0%
+109.0%

More News

Read More
News headline image
Jazz Pharmaceuticals (JAZZ): Buy, Sell, or Hold Post Q1 Earnings?
June 15, 2026
Via StockStory
Topics Stocks
News headline image
Pharmaceuticals Stocks Q1 Recap: Benchmarking Jazz Pharmaceuticals (NASDAQ:JAZZ)
June 14, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) Presents a Decent Value Opportunity with Strong Valuation and Growth Potential ↗
June 09, 2026
Via Chartmill
Jazz Pharmaceuticals (NASDAQ:JAZZ) Flashes Perfect Minervini Trend Template Score with 116% Annual Surge ↗
June 05, 2026
Via Chartmill
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surges 3.7% After-Hours on Q1 2026 Revenue and EPS Beat ↗
May 05, 2026
Via Chartmill
News headline image
3 Unpopular Stocks We Find Risky
June 08, 2026
Via StockStory
Topics Credit Cards
News headline image
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks We Think Twice About
May 29, 2026
Via StockStory
News headline image
3 Mid-Cap Stocks We’re Skeptical Of
May 25, 2026
Via StockStory
News headline image
Is Marriott Stock a Buy After GMT Capital Initiated a Position Worth Over $66 Million? ↗
May 20, 2026
Via The Motley Fool
News headline image
Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 12, 2026
Via StockStory
Topics Earnings
News headline image
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
May 06, 2026
Via StockStory
News headline image
JAZZ Q1 Deep Dive: Oncology and Neuroscience Drive Double-Digit Revenue Growth, Eyes on Upcoming Approvals
May 06, 2026
Via StockStory
News headline image
Jazz (JAZZ) Q1 2026 Earnings Call Transcript ↗
May 05, 2026
Via The Motley Fool
Topics Earnings
News headline image
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales
May 05, 2026
Via StockStory
News headline image
Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For
May 03, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
April 26, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Overrated Stocks with Warning Signs
April 23, 2026
Via StockStory
News headline image
3 Reasons to Sell JAZZ and 1 Stock to Buy Instead
April 21, 2026
Via StockStory
News headline image
Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
April 06, 2026
Via MarketMinute
News headline image
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
March 31, 2026
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
1 Value Stock to Research Further and 2 We Ignore
March 18, 2026
Via StockStory
News headline image
3 Healthcare Stocks Walking a Fine Line
March 13, 2026
Via StockStory

Frequently Asked Questions

Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 224.66
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 06/18/26 04:00 PM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 14.00B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap